pravastatin has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, LP; Li, L; Nie, SN; Ren, Y; Sun, ZR; Wang, MM; Yang, ZZ; Zhang, P; Zhang, W | 1 |
| Bauer, I; Beck, C; Herminghaus, A; Picker, O; Schulz, J; Truse, R; Vollmer, C | 1 |
2 other study(ies) available for pravastatin and Sepsis
| Article | Year |
|---|---|
Pravastatin attenuates sepsis-induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of Cav-1/eNOS pathway.
Topics: Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Capillary Permeability; Caveolin 1; Disease Models, Animal; Endothelial Cells; Humans; Male; Mice; Nitric Oxide Synthase Type III; Pravastatin; Pulmonary Alveoli; Sepsis | 2021 |
Effect of Pravastatin Pretreatment and Hypercapnia on Intestinal Microvascular Oxygenation and Blood Flow During Sepsis.
Topics: Animals; Gastric Mucosa; Hemodynamics; Hypercapnia; Male; Microcirculation; Oxygen; Pravastatin; Rats; Rats, Wistar; Sepsis | 2020 |